34168-56-4 Usage
Uses
Used in Pharmaceutical Industry:
Catalpol is used as a therapeutic agent for its anti-inflammatory and antioxidant properties, which may help in managing various health conditions and supporting brain health.
Used in Neuroprotection:
Catalpol is used as a neuroprotective agent for its potential to support brain health and prevent neurodegenerative disorders.
Used in Diabetes Management:
Catalpol is used as a diabetes management agent for its potential to enhance insulin secretion and improve glucose tolerance, which may help in managing blood sugar levels.
Used in Cancer Therapy:
Catalpol is used as an anti-cancer agent for its potential to inhibit cancer cell growth and proliferation, making it a promising candidate for further research and development in cancer treatment.
Used in Anti-Aging Applications:
Catalpol is used as an anti-aging agent for its potential to delay the aging process and promote overall health and longevity.
Check Digit Verification of cas no
The CAS Registry Mumber 34168-56-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,1,6 and 8 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 34168-56:
(7*3)+(6*4)+(5*1)+(4*6)+(3*8)+(2*5)+(1*6)=114
114 % 10 = 4
So 34168-56-4 is a valid CAS Registry Number.
InChI:InChI=1/C15H18O2/c1-10(2)7-8-11-9-14(16)12-5-3-4-6-13(12)15(11)17/h3-7,11,14,16H,8-9H2,1-2H3/t11-,14+/m1/s1
34168-56-4Relevant academic research and scientific papers
Efficient enantioselective syntheses of sertraline, 2-epicatalponol and catalponol from tetralin-1,4-dione
Garcia, Alvaro Enriquez,Ouizem, Souad,Cheng, Xin,Romanens, Patrick,Kuendig, E. Peter
experimental part, p. 2306 - 2314 (2010/11/19)
Tetralin-1,4-dione, the stable tautomer of dihydroxynaphthalene, was reduced with catecholborane in the presence of 3,3-diphenyl-1-butyltetrahydro- 3H-pyrrolo[1,2-c][1,3,2]oxazaborole as catalyst to give enantiomerically highly enriched 4-hydroxy1-tetralone (99% ee) in an efficient one-pot procedure. The R-enantiomer provided a rapid access to sertraline while the S-enantiomer was converted into 2-epicatalponol and catalponol. A more selective enantioselective route to the antithermitic catalponol made use of the planar chiral tricarbonylchromium complex of hydroxytetralone. Its precursor chromium(tricarbonyl)[η6-(1-4,4a,8a)-tetralin-5,8dione] was obtained via direct complexation of 1,4-dihydroxynaphthalene using chromium(tricarbonyl)tris(ammonia) and boron trifluoride etherate as source of the chromium(tricarbonyl) fragment. Enolate prenylation was best carried out in the presence of a tetraamine ligand. Complete inversion of the stereogenic center bearing the prenyl group of the initially obtained tetralone complex was achieved via enolate formation followed by protonation.
